Enanta Pharmaceuticals Inc. sell StockNews.com
Start price
02.09.23
/
50%
€13.00
Target price
02.09.24
-
Performance (%)
-14.62%
End price
03.09.24
€11.10
Summary
This prediction ended on 03.09.24 with a price of €11.10. The price of Enanta Pharmaceuticals Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -14.62%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Enanta Pharmaceuticals Inc. | 8.411% | 8.411% | 47.771% |
| iShares Core DAX® | 0,39 % | 0,15 % | 10,96 % |
| iShares Nasdaq 100 | 1,31 % | -2,55 % | -0,61 % |
| iShares Nikkei 225® | -0,46 % | 6,89 % | 26,75 % |
| iShares S&P 500 | 1,31 % | -1,16 % | -0,04 % |
Comments by StockNews_com for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ENTA provided by MarketBeat
In the thread Trading Enanta Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.20
06.04.24
06.04.24
-
06.04.25
06.04.25
-72.89%
07.04.25
07.04.25
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.70
30.09.23
30.09.23
-
30.09.24
30.09.24
-10.75%
01.10.24
01.10.24